Amazon Pharmacy (NASDAQ: AMZN) announced it now offers Eli Lilly's Zepbound KwikPen for weight management with transparent cash-pay pricing starting at $299 per month for the 2.5 mg starter dose.

The multi-dose injectable treatment delivers a full month of medication in a single device, designed to reduce the number of single-dose devices required for patients. Customers with valid prescriptions can order the medication through Amazon Pharmacy's platform and receive home delivery.

Zepbound is approved by regulators to help adults lose weight and maintain weight loss when used with diet and exercise. The medication is also approved for treating adults with obesity and moderate-to-severe obstructive sleep apnea.

"By expanding access to the Zepbound KwikPen with upfront self-pay pricing, we're making it easier for customers to get the treatments their doctors prescribe in a simpler way—delivered directly and reliably to their homes," said Tanvi Patel, Vice President and General Manager of Amazon Pharmacy.

Amazon Pharmacy has delivered GLP-1 medications since 2021 and partners with healthcare providers and digital health companies including LillyDirect, WeightWatchers, UpScriptHealth and Noom. The service automatically applies manufacturer-sponsored coupons at checkout, with customers saving more than $200 million to date through the program.

The pharmacy offers same-day delivery to nearly 3,000 cities and towns, with plans to expand to nearly 4,500 locations by the end of 2026. Customers receive free delivery on their first order of each new medication.

Amazon One Medical provides additional weight management support through clinical evaluations and ongoing care management for customers seeking comprehensive treatment options.